Literature DB >> 20737807

[Expensive drugs and intergenerational justice].

David Hughes1.   

Abstract

Among all categories of health expenditure in Canada, spending on drugs is the fastest growing. The factors at play in the increase in expenditure on drugs are essentially those related to the volume of use and the arrival of new drugs on the market. Some of these new drugs are very expensive. In fact, the costs of certain drugs threaten the continued existence of the Québec Prescription Drug Insurance Plan. In Québec, the Conseil du médicament (Drug Board) is responsible for recommending drugs to the Ministry of Health and Social Services to be put on the formulary of drugs covered by the public plan. In spite of pressure by various stakeholders, we believe that the rationing of drugs that are too expensive can achieve political legitimacy if it is based on a transparent justification that includes not only evidence-based criteria, but also ethical principles and values. For egalitarians, fairness in the supply of health care should be accomplished as a function of health care needs. But this concept of justice should also be extended to future generations. The balance of current and future needs should be achieved by determining what would be "reasonable access" through public consultations among experts and citizens.

Entities:  

Mesh:

Year:  2010        PMID: 20737807      PMCID: PMC6973836     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  5 in total

1.  The great escape? Prospects for regulating access to technology through health technology assessment.

Authors:  Mira Johri; Pascale Lehoux
Journal:  Int J Technol Assess Health Care       Date:  2003       Impact factor: 2.188

2.  Redefining health technology assessment in Canada: diversification of products and contextualization of findings.

Authors:  Pascale Lehoux; Stéphanie Tailliez; Jean-Louis Denis; Myriam Hivon
Journal:  Int J Technol Assess Health Care       Date:  2004       Impact factor: 2.188

Review 3.  Equity and population health: toward a broader bioethics agenda.

Authors:  Norman Daniels
Journal:  Hastings Cent Rep       Date:  2006 Jul-Aug       Impact factor: 2.683

4.  Mapping the integration of social and ethical issues in health technology assessment.

Authors:  Pascale Lehoux; Bryn Williams-Jones
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

5.  Technology assessment and the sociopolitics of health technologies.

Authors:  P Lehoux; S Blume
Journal:  J Health Polit Policy Law       Date:  2000-12       Impact factor: 2.265

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.